Applied DNA Sciences (NASDAQ:APDN) perks up 8% premarket on average volume in reaction to its announcement that it has completed the design of a diagnostic kit for SARS-CoV-2, the coronavirus causing COVID-19.
In vitro verification of the in silico analysis
(which showed the test to be highly accurate and specific) will be
completed in the coming weeks.
https://seekingalpha.com/news/3553265-applied-dna-sciences-completes-design-of-coronavirus-test-shares-up-8-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.